Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microglia activation states and cannabinoid system: Therapeutic implications
Míriam Mecha, Francisco Carrillo‐Salinas, Ana Feliú, et al.
Pharmacology & Therapeutics (2016) Vol. 166, pp. 40-55
Closed Access | Times Cited: 139

Showing 1-25 of 139 citing articles:

Bioactive Lipids and Chronic Inflammation: Managing the Fire Within
Valerio Chiurchiù, Alessandro Leuti, Mauro Maccarrone
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 375
Bioactive lipids, inflammation and chronic diseases
Alessandro Leuti, Domenico Fazio, Marina Fava, et al.
Advanced Drug Delivery Reviews (2020) Vol. 159, pp. 133-169
Closed Access | Times Cited: 234
Immune regulation in the aging retina
Mei Chen, Chang Luo, Jiawu Zhao, et al.
Progress in Retinal and Eye Research (2018) Vol. 69, pp. 159-172
Open Access | Times Cited: 211
The biological pathways of Alzheimer disease: a review
Marco Calabrò, Carmela Rinaldi, Giuseppe Santoro, et al.
AIMS neuroscience (2020) Vol. 8, Iss. 1, pp. 86-132
Open Access | Times Cited: 180
Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
Tommaso Cassano, Silvio Calcagnini, Lorenzo Pace, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 171
Microglia-neuron crosstalk: Signaling mechanism and control of synaptic transmission
Silvia Marinelli, Bernadette Basilico, Maria Cristina Marrone, et al.
Seminars in Cell and Developmental Biology (2019) Vol. 94, pp. 138-151
Closed Access | Times Cited: 167
Microglia and Neuroinflammation: Crucial Pathological Mechanisms in Traumatic Brain Injury-Induced Neurodegeneration
Fangjie Shao, Xiaoyu Wang, Haijian Wu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 139
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Minghui Wang, Hu Zhang, Jiling Liang, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 80
Advances in Alzheimer's disease: A multifaceted review of potential therapies and diagnostic techniques for early detection
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta
Neurochemistry International (2024) Vol. 177, pp. 105761-105761
Closed Access | Times Cited: 15
Therapeutic potential of extracellular vesicles derived from human mesenchymal stem cells in a model of progressive multiple sclerosis
Fernando Laso-García, Jaime Ramos‐Cejudo, Francisco Carrillo‐Salinas, et al.
PLoS ONE (2018) Vol. 13, Iss. 9, pp. e0202590-e0202590
Open Access | Times Cited: 135
Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges
Attila Oláh, Zoltán Szekanecz, Tamás Bı́ró
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 118
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases
Valerio Chiurchiù, Mario van der Stelt, Diego Centonze, et al.
Progress in Neurobiology (2017) Vol. 160, pp. 82-100
Open Access | Times Cited: 116
Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer’s disease and levodopa-induced dyskinesia
Gemma Navarro, Dasiel O. Borroto‐Escuela, Edgar Angelats, et al.
Brain Behavior and Immunity (2017) Vol. 67, pp. 139-151
Closed Access | Times Cited: 104
Enforced microglial depletion and repopulation as a promising strategy for the treatment of neurological disorders
Jinming Han, Keying Zhu, Xing‐Mei Zhang, et al.
Glia (2018) Vol. 67, Iss. 2, pp. 217-231
Open Access | Times Cited: 91
Stress-induced blood brain barrier disruption: Molecular mechanisms and signaling pathways
Menizibeya O. Welcome, Nikos E. Mastorakis
Pharmacological Research (2020) Vol. 157, pp. 104769-104769
Closed Access | Times Cited: 90
The cannabinoid system and microglia in health and disease
Samuel S. Duffy, Jessica P. Hayes, Nathan T. Fiore, et al.
Neuropharmacology (2021) Vol. 190, pp. 108555-108555
Closed Access | Times Cited: 71
Microglial Inflammatory-Metabolic Pathways and Their Potential Therapeutic Implication in Major Depressive Disorder
Reza Rahimian, Claudia Belliveau, Rebecca Chen, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 46
Cannabidiol - a friend or a foe?
Bianca-Maria Tihăuan, Tatiana Onisei, Walter Slootweg, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107036-107036
Open Access | Times Cited: 1
Therapeutic applications of cannabinoids
Nancy Maurya, Bharath Kumar Velmurugan
Chemico-Biological Interactions (2018) Vol. 293, pp. 77-88
Closed Access | Times Cited: 69
Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2
Sabrina F. Lisboa, Anzela Niraula, Leonardo B.M. Resstel, et al.
Neuropsychopharmacology (2018) Vol. 43, Iss. 9, pp. 1924-1933
Open Access | Times Cited: 66
Blood-retinal barrier as a converging pivot in understanding the initiation and development of retinal diseases
Xue Yang, Xiaowei Yu, Dandan Zhang, et al.
Chinese Medical Journal (2020) Vol. 133, Iss. 21, pp. 2586-2594
Open Access | Times Cited: 54
Microglia and BDNF at the crossroads of stressor related disorders: Towards a unique trophic phenotype
Natalie Prowse, Shawn Hayley
Neuroscience & Biobehavioral Reviews (2021) Vol. 131, pp. 135-163
Open Access | Times Cited: 47
Non‐psychotropic Cannabis sativa L. phytocomplex modulates microglial inflammatory response through CB2 receptors‐, endocannabinoids‐, and NF‐κB‐mediated signaling
Vittoria Borgonetti, Cristina Benatti, Paolo Governa, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 5, pp. 2246-2263
Open Access | Times Cited: 33
Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells
Ana Bernal‐Chico, Vanja Tepavčević, Andrea Manterola, et al.
Glia (2022) Vol. 71, Iss. 1, pp. 103-126
Open Access | Times Cited: 29
Psychiatric Comorbidities of Inflammatory Bowel Disease: It Is a Matter of Microglia’s Gut Feeling
Gohar Fakhfouri, Nataša R. Mijailović, Reza Rahimian
Cells (2024) Vol. 13, Iss. 2, pp. 177-177
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top